Skip to main content
. 2020 Dec 11;27(4):611–617. doi: 10.1016/j.cmi.2020.12.003

Fig. 1.

Fig. 1

Study cohort, classification according to hydroxychloroquine use, and diagnosis of coronavirus disease 2019 (COVID-19). RA, rheumatoid arthritis; SLE, systemic lupus erythematosus.